Related Experiment Video
Updated: Mar 7, 2026

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
Impact of oxidative and antioxidative potential on cancer risk: the Japan Public Health Center-based Prospective
Kenshiro Nishihara1,2, Taiki Yamaji3, Yukai Lu4
1Division of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Background:
This study aimed to elucidate the impact of systemic shifts towards increased oxidative or antioxidative potential on cancer development and suppression. Given that longitudinal studies on cancer associations are limited for plasma levels of derivatives of reactive oxygen metabolite (d-ROM) and biological antioxidant potential (BAP), we investigated the associations of these robust biomarkers with risk of overall and multiple site-specific cancers.
Methods:
We designed a case-cohort study within a large Japanese population-based prospective study. Plasma d-ROM and BAP were measured in 4718 cancer cases and 4815 randomly selected subcohort individuals, who were followed for a mean period of 15.5 years. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using a weighted Cox proportional hazards model.
Results:
Compared to the lowest quartiles, the highest quartiles of d-ROM showed a multivariable adjusted HR of 1.69 (95% CI = 1.08-2.64; ptrend = 0.02) for hepatocellular carcinoma and 1.32 (95% CI = 1.01-1.72; ptrend = 0.01) for lung cancer. Conversely, the highest quartile of BAP for gastric cancer was 0.80 (95% CIs = 0.63-1.01; ptrend = 0.03).
Conclusions:
These findings suggest a potential impact of oxidation and antioxidation on cancer development at specific sites.
More Related Videos
Related Concept Videos
Cancer Prevention
Some...
Mutagenicity and Carcinogenicity
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Radical Autoxidation

